Use of HDAC inhibitors for the treatment of Hodgkin's disease

Details for Australian Patent Application No. 2009270886 (hide)

Owner Novartis AG

Inventors Atadja, Peter Wisdom

Agent Davies Collison Cave

Pub. Number AU-A-2009270886

PCT Pub. Number WO2010/009280

Priority 61/081,805 18.07.08 US

Filing date 16 July 2009

Wipo publication date 21 January 2010

International Classifications

A61K 31/00 (2006.01)

A61K 31/404 (2006.01)

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/009280 Priority application(s): WO2010/009280

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009270899-Carton with handle

2009270879-CO2 utilization in electrochemical systems